Association study of dimethylarginine dimethylaminohydrolase 2 gene polymorphisms and coronary heart disease

Xu,Ai-Guo; Xu,Rong-Mei; Lu,Chang-Qing; Li,Dan-Dan; Xu,Qin‑Fu; Guo,Jing; Fu,Xin; Zhao,Wei; Yao,Meng-Ying

doi:10.3892/mmr.2012.1038

November 2012 Volume 6 Issue 5

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

November 2012 Volume 6 Issue 5

Full Size Image

Article

Association study of dimethylarginine dimethylaminohydrolase 2 gene polymorphisms and coronary heart disease

Authors:
- Ai-Guo Xu
- Rong-Mei Xu
- Chang-Qing Lu
- Dan-Dan Li
- Qin‑Fu Xu
- Jing Guo
- Xin Fu
- Wei Zhao
- Meng-Ying Yao
View Affiliations / Copyright

Affiliations: Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China , Human Science Laboratory, Institute of Physical Education of Henan Polytechnic University, Jiaozuo, Henan 454000, P.R. China, Department of Laboratory Medicine, The Second Affiliated Hospital, Henan University of Traditional Chinese Medicine, Zhengzhou, Henan 450052, P.R. China
Pages: 1103-1106
|
Published online on: August 16, 2012

https://doi.org/10.3892/mmr.2012.1038
Expand metrics +

Abstract

While a number of genetic and environmental risk factors for coronary heart disease (CHD) have been identified, the list of potential risk factors remains long. One candidate is dimethylarginine dimethylaminohydrolase (DDAH2), which is known to be polymorphic in humans. The gene product indirectly increases the endogenous production of nitric oxide, an anti-atherogenic molecule. Therefore, alterations in DDAH2 activity may indirectly result in an increased risk of CHD. We studied allele and genotype distributions for two polymorphic loci of DDAH2, rs805305 and rs2272592, in 180 patients with CHD and 180 healthy controls. Disease history and other clinical data were recorded. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was used to determine the genotype at rs805305, and ligase detection reaction (LDR) was used to determine the genotype at rs2272592. Systolic blood pressure and blood triglyceride and glucose levels were higher, and history of hypertension, diabetes, smoking and alcohol use was more common in the patients with CHD (P<0.05). However, the genotype and allele frequencies at the two polymorphic loci of DDAH2 were not statistically different between the two groups. Therefore, no association was observed between the DDAH2 polymorphisms at rs805305 and rs2272592 and CHD.

View Figures

View References

1	Gaziano TA, Bitton A, Anand S, Abrahams-Gessel S and Murphy A: Growing epidemic of coronary heart disease in low- and middle-income countries. Curr Probl Cardiol. 35:72–115. 2010.PubMed/NCBI
2	Tearney GJ, Regar E, Akasaka T, et al: Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol. 59:1058–1072. 2012. View Article : Google Scholar
3	Kolovou G and Giannakopoulou V: Endothelial nitric oxide synthase gene variants and coronary heart disease. Angiology. 63:84–85. 2012. View Article : Google Scholar : PubMed/NCBI
4	Chen X, Niroomand F, Liu Z, Zankl A, Katus HA, Jahn L and Tiefenbacher CP: Expression of nitric oxide related enzymes in coronary heart disease. Basic Res Cardiol. 101:346–353. 2006. View Article : Google Scholar : PubMed/NCBI
5	Jia CQ, Ning Y, Liu TT and Liu ZL: Association between G894T mutation in endothelial nitric oxide synthase gene and premature coronary heart disease. Zhonghua Liu Xing Bing Xue Za Zhi. 26:51–53. 2005.(In Chinese).
6	Celik M, Iyisoy A, Celik T, Yilmaz MI, Yuksel UC and Yaman H: The relationship between L-arginine/ADMA ratio and coronary collateral development in patients with low glomerular filtration rate. Cardiol J. 19:29–35. 2012. View Article : Google Scholar : PubMed/NCBI
7	Palm F, Onozato ML, Luo Z and Wilcox CS: Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems. Am J Physiol Heart Circ Physiol. 293:H3227–H3245. 2007. View Article : Google Scholar : PubMed/NCBI
8	Gad MZ, Hassanein SI, Abdel-Maksoud SM, et al: Assessment of serum levels of asymmetric dimethylarginine, symmetric dimethylarginine and L-arginine in coronary artery disease. Biomarkers. 15:746–752. 2010. View Article : Google Scholar : PubMed/NCBI
9	Abhary S, Burdon KP, Kuot A, Javadiyan S, Whiting MJ, Kasmeridis N, Petrovsky N and Craig JE: Sequence variation in DDAH1 and DDAH2 genes is strongly and additively associated with serum ADMA concentrations in individuals with type 2 diabetes. PLoS One. 5:e94622010. View Article : Google Scholar : PubMed/NCBI
10	Maas R, Erdmann J, Lüneburg N, et al: Polymorphisms in the promoter region of the dimethylarginine dimethylaminohydrolase 2 gene are associated with prevalence of hypertension. Pharmacol Res. 60:488–493. 2009. View Article : Google Scholar : PubMed/NCBI
11	Wang YZ, Xiao JH, Liu LG, Ye CY, Shen HY, Xu TM and Zhu KZ: Simultaneous detection of hepatitis B virus genotypes and mutations associated with resistance to lamivudine, adefovir, and telbivudine by the polymerase chain reaction-ligase detection reaction. Braz J Infect Dis. 15:560–566. 2011. View Article : Google Scholar
12	Alasbahi RH and Melzig MF: Forskolin and derivatives as tools for studying the role of cAMP. Pharmazie. 67:5–13. 2012.PubMed/NCBI
13	Houston M: The role of magnesium in hypertension and cardiovascular disease. J Clin Hypertens (Greenwich). 13:843–847. 2011. View Article : Google Scholar : PubMed/NCBI
14	Anthony S, Leiper J and Vallance P: Endogenous production of nitric oxide synthase inhibitors. Vasc Med. (Suppl 1)10:S3–S9. 2005. View Article : Google Scholar
15	Maas R: Pharmacotherapies and their influence on asymmetric dimethylargine (ADMA). Vasc Med. (Suppl 1)10:S49–S57. 2005. View Article : Google Scholar : PubMed/NCBI
16	Tatematsu S, Wakino S, Kanda T, et al: Role of nitric oxide-producing and -degrading pathways in coronary endothelial dysfunction in chronic kidney disease. J Am Soc Nephrol. 18:741–749. 2007. View Article : Google Scholar : PubMed/NCBI
17	Leiper J, Nandi M, Torondel B, et al: Disruption of methylarginine metabolism impairs vascular homeostasis. Nat Med. 13:198–203. 2007. View Article : Google Scholar : PubMed/NCBI
18	Zand Parsa AF, Ziai H and Haghighi L: The impact of cardiovascular risk factors on the site and extent of coronary artery disease. Cardiovasc J Afr. 23:197–199. 2012.PubMed/NCBI
19	Jones LC, Tran CT, Leiper JM, Hingorani AD and Vallance P: Common genetic variation in a basal promoter element alters DDAH2 expression in endothelial cells. Biochem Biophys Res Commun. 310:836–843. 2003. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Association study of dimethylarginine dimethylaminohydrolase 2 gene polymorphisms and coronary heart disease

This article is mentioned in:

Abstract

Figure 1

Figure 2

Related Articles